TGFb2 induces the soluble isoform of CTLA-4 – implications for CTLA-4 based checkpoint inhibitor antibodies in malignant melanoma
Date
2022-01-05
Journal Title
Journal ISSN
Volume Title
Publisher
Citation
Khanolkar, R C, Zhang, C, al-Fatyan, F, Lawson, L G, Depasquale, I, Meredith, F, Muller, F, Nicolson, M, Dahal, L N, Abu Eid, R, Rajpara, S, Barker, R N, Ormerod, A & Ward, F J 2022, 'TGFb2 induces the soluble isoform of CTLA-4 – implications for CTLA-4 based checkpoint inhibitor antibodies in malignant melanoma', Frontiers in Immunology, vol. 12, 763877. https://doi.org/10.3389/fimmu.2021.763877